Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Four dimensions of individualization in brain stimulation for psychiatric disorders: context, target, dose, and timing
    Published on 2025-03-26
    1 year ago
  • Early-life adversity alters adult nucleus incertus neurons: implications for neuronal mechanisms of increased stress and compulsive behavior vulnerability
    Published on 2025-03-20
    1 year ago
  • Central Med23 deficiency leads to malformation of dentate gyrus and ADHD-like behaviors in mice
    Published on 2025-03-19
    1 year ago
  • Preregistered multi-site preclinical randomized controlled trials: the beginning of a new day in reverse translational science?
    Published on 2025-03-19
    1 year ago
  • Grey matter morphometry in young adult e-cigarette users, tobacco cigarette users & non-using controls
    Published on 2025-03-18
    1 year ago
  • Correction: Neuropsychopharmacology Volume 50 Issue 1
    Published on 2025-03-18
    1 year ago
  • The role of sex in the association between cannabis use disorder and resting-state functional connectivity
    Published on 2025-03-17
    1 year ago
« Previous 1 … 66 67 68 69 70 … 143 Next »
Journal of Psychopharmacology
  • Sub-acute effects of psilocybin on EEG correlates of neural plasticity in major depression: Relationship to symptoms
    Published on 2023-07-01
    3 years ago
  • Harnessing placebo: Lessons from psychedelic science
    Published on 2023-07-01
    3 years ago
  • Body mass index, waist circumference, insulin, and leptin plasma levels differentiate between clozapine-responsive and clozapine-resistant schizophrenia
    Published on 2023-06-28
    3 years ago
  • The New Zealand drug harms ranking study: A multi-criteria decision analysis
    Published on 2023-06-24
    3 years ago
  • Baseline cognitive function predicts full remission of suicidal symptoms among patients with treatment-resistant depression and strong suicidal ideation after low-dose ketamine infusion
    Published on 2023-06-19
    3 years ago
  • The histamine system and cognitive function: An in vivo H3 receptor PET imaging study in healthy volunteers and patients with schizophrenia
    Published on 2023-06-17
    3 years ago
  • Acute neurocognitive and subjective effects of oral methamphetamine with low doses of alcohol: A randomised controlled trial
    Published on 2023-06-14
    3 years ago
« Previous 1 … 66 67 68 69 70 … 154 Next »
European Neuropsychopharmacology
  • Factors associated with lamotrigine concentration/dose ratio in individuals with bipolar disorders
    Published on 2023-05-04
    3 years ago
  • Contributions of circadian clock genes to cell survival in fibroblast models of lithium-responsive bipolar disorder
    Published on 2023-04-30
    3 years ago
  • A randomized controlled trial of add-on naproxen, simvastatin and their combination for the treatment of schizophrenia or schizoaffective disorder
    Published on 2023-04-30
    3 years ago
  • The long path ahead of robotics in psychiatry
    Published on 2023-04-28
    3 years ago
  • Prediction of postpartum depression with an online neurocognitive risk screening tool for pregnant women
    Published on 2023-04-28
    3 years ago
  • Psychopathology for the twenty-first century: Towards a ChatGPT psychopathology?
    Published on 2023-04-28
    3 years ago
  • A systematic review of manic/hypomanic and depressive switches in patients with bipolar disorder in naturalistic settings: The role of antidepressant and antipsychotic drugs
    Published on 2023-04-27
    3 years ago
« Previous 1 … 66 67 68 69 70 … 170 Next »

   Pharma Pub